Cargando…
Remimazolam: An Updated Review of a New Sedative and Anaesthetic
Remimazolam (CNS7056) is a novel benzodiazepine for intravenous sedation; it has an ultra-short duration of action and was recently approved for use in procedural sedation and general anaesthesia. It acts on γ-aminobutyric acid type A receptors and is rapidly converted into an inactive metabolite by...
Autores principales: | Hu, Qinxue, Liu, Xing, Wen, Chengli, Li, Duo, Lei, Xianying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675580/ https://www.ncbi.nlm.nih.gov/pubmed/36411859 http://dx.doi.org/10.2147/DDDT.S384155 |
Ejemplares similares
-
Review of remimazolam and sedatives in the intensive care unit
por: Choi, Hey-Ran, et al.
Publicado: (2022) -
Remimazolam: The future of its sedative potential
por: Goudra, Basavana Gouda, et al.
Publicado: (2014) -
Chloral, the New Sedative and Anæsthetic
Publicado: (1869) -
Remimazolam for Sedation During Fiberoptic Intubation in an Adolescent
por: Hughes, Mitchell, et al.
Publicado: (2023) -
The effective doses of remimazolam besylate in the procedural sedation of endoscopic retrograde cholangiopancreatography
por: Tan, Dan‐Dan, et al.
Publicado: (2022)